Breast Cancer Clinical Trials

Showing 1901-1920 of 4,817 trials

Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk

NCT04257474

This study seeks to develop an explanatory framework for breast MRI utilization to inform future interventions. The Health Services Utilization Model (HSUM) will guide the selection of specific participant-level factors for examination, including predisposing characteristics (knowledge, health/cultural beliefs), enabling resources (social support, cost/insurance coverage), and perceived need (perceived susceptibility, provider recommendation).

Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute265 participantsStarted Jan 2020

Washington D.C., District of Columbia, United States • Tampa, Florida, United States

COMPLETEDPhase 3

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

NCT00295646

The primary objective is, first, the comparison of tamoxifen and anastrozole and, second, the comparison of zoledronate added to standard adjuvant therapy with controls according to disease-free survival (DFS) in premenopausal patients with non-metastatic breast cancer treated with tamoxifen or anastrozole. To assess whether zoledronate added to standard adjuvant therapy can decrease or even prevent bone loss in patients treated with hormonal blockade combined with an antiestrogen or aromatase inhibitor.

Breast Cancer

Austrian Breast & Colorectal Cancer Study Group1,803 participantsStarted Jun 1999

Güssing, Burgenland, Austria • Oberpullendorf, Burgenland, Austria • Oberwart, Burgenland, Austria +69 more locations

Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

Related Searches

Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"

Neoadjuvant Radiotherapy for Breast Cancer

Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial

CO2 Laser Therapy for the Treatment of GSM in Patients With Breast Cancer

Non-Viral TCR Gene Therapy

Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer

Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block

Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

HR+/HER2- Advanced Breast Cancer and Endocrine Resistance

Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy

Effects of Diet and Osteopathy on Quality of Life and Inflammation in Breast Cancer Patients Under Hormonal Therapy

Online Psychosocial Cancer Screening, Monitoring and Stepped Treatment in Cancer Survivors

Care Coordination for Complex Cancer Survivors in an Integrated Safety Net System

A European Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced (LA) or Metastatic Breast Cancer (mBC) (SAMANTHA)

Comparing 5 and 15 Fractions for Whole Breast Irradiation After Breast Conserving Surgery

Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients